Italy's Philogen sets IPO price range at between 15-18 euros/shr

ROME, Feb 16 (Reuters) - Italian-Swiss biotechnology company Philogen said on Tuesday it had set an indicative price range for its initial public offering of between 15-18 euros per share.

The company said earlier this month it planned to offer up to 4,061,111 new shares - or 10% of its capital - in an IPO expected in the first quarter of 2021.

The price range values the whole of the company, including the planned capital increase, at between 609-731 million euros ($740-888 million), it added in a statement.

($1 = 0.8230 euros)

(Reporting by Francesca Piscioneri; editing by Agnieszka Flak)

((; +390680307713;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.